Provention bio to present at the virtual svb leerink 11th annual global healthcare conference

Red bank, n.j., feb. 10, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a fireside chat presentation at the svb leerink 11th annual global healthcare conference on wednesday, february 16 th, 2022 at 10:00am est.
PRVB Ratings Summary
PRVB Quant Ranking